Target: Martin Makary, Commissioner of the U.S. Food and Drug Administration
Goal: Don’t allow use of the drug Experior, which is reported to cause serious health issues in cattle.
The approval of Experior, a cattle drug by Elanco Animal Health, raises serious concerns over safety protocols followed by the U.S. Food and Drug Administration (FDA). Reports indicate that despite alarming findings from multiple studies indicating that cattle treated with Experior experienced significant health issues such as lameness and life-threatening bloat, the FDA proceeded to approve this drug primarily based on its alleged environmental benefits. Such a decision reflects a disturbing trend where human and animal safety may be compromised for corporate interests, potentially endangering both livestock welfare and public health.
Investigations reveal that cattle receiving Experior more frequently suffered from conditions that can lead to death, with several adverse reports documenting the deaths of cattle, linked to the drug. The FDA’s approval process has been scrutinized as it seems to lack rigor, particularly given that the studies supporting the drug’s safety did not accurately reflect conditions in typical feedlot environments. This negligence raises questions about the integrity of the approval process, suggesting a priority placed on quick market access rather than thorough scientific evaluation.
It is essential to demand accountability for these actions, as the impacts of this drug extend beyond animal welfare, hinting at potential risks for human consumers of beef. The ongoing use of Experior, linked to the rise in health problems and mortality rates in cattle, calls for immediate review and punishment for those who failed to protect both animal and public health. The demand is clear: those responsible for the allegedly negligent approval of Experior must be held accountable.
PETITION LETTER:
Dear Commissioner Makary,
The approval of Experior has raised alarming concerns regarding animal welfare and public health. Investigations have revealed that cattle administered with Experior experienced severe health issues, including increased incidences of lameness and life-threatening bloat. Notably, these issues were documented in studies resulting in troubling findings—yet the FDA chose to approve the drug based on its supposed environmental benefits rather than safeguarding animal safety. This decision raises questions about the integrity and efficacy of the FDA’s review process.
We demand that the FDA reconsider its approval of Experior, and protect animals from unnecessary harm.
Sincerely,
[Your Name Here]
Photo credit: Pixabay
